Fasudil prevents KATP channel-induced improvement in postischemic functional recovery

Am J Physiol Heart Circ Physiol. 2005 Jun;288(6):H3011-5. doi: 10.1152/ajpheart.00611.2004. Epub 2005 Feb 4.

Abstract

Whereas activation of ATP-dependent potassium (K(ATP)) channels greatly improves postischemic myocardial recovery, the final effector mechanism for K(ATP) channel-induced cardioprotection remains elusive. RhoA is a GTPase that regulates a variety of cellular processes known to be involved with K(ATP) channel cardioprotection. Our goal was to determine whether the activity of a key rhoA effector, rho kinase (ROCK), is required for K(ATP) channel-induced cardioprotection. Four groups of perfused rat hearts were subjected to 36 min of zero-flow ischemia and 44 min of reperfusion with continuous measurements of mechanical function and (31)P NMR high-energy phosphate data: 1) untreated, 2) pinacidil (10 microM) to activate K(ATP) channels, 3) fasudil (15 microM) to inhibit ROCK, and 4) both fasudil and pinacidil. Pinacidil significantly improved postischemic mechanical recovery [39 +/- 16 vs. 108 +/- 4 mmHg left ventricular diastolic pressure (LVDP), untreated and pinacidil, respectively]. Fasudil did not affect reperfusion LVDP (41 +/- 13 mmHg) but completely blocked the marked improvement in mechanical recovery that occurred with pinacidil treatment (54 +/- 15 mmHg). Substantial attenuation of the postischemic energetic recovery was also observed. These data support the hypothesis that ROCK activity plays a role in K(ATP) channel-induced cardioprotection.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / analogs & derivatives*
  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / pharmacology*
  • Animals
  • Heart / physiology*
  • Heart / physiopathology
  • In Vitro Techniques
  • Magnetic Resonance Spectroscopy
  • Male
  • Myocardial Ischemia / physiopathology*
  • Myocardial Ischemia / prevention & control
  • Pinacidil / pharmacology
  • Potassium Channel Blockers / pharmacology*
  • Potassium Channels / drug effects
  • Potassium Channels / physiology*
  • Rats
  • Rats, Sprague-Dawley
  • Vasodilator Agents / pharmacology

Substances

  • Potassium Channel Blockers
  • Potassium Channels
  • Vasodilator Agents
  • Pinacidil
  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
  • fasudil